General MedicationsINJECTIONStandard
CEFTRIAXONE
CEFTRIAXONE SODIUM
Standard Dose
EQ 10GM BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview CEFTRIAXONE is listed in Drugs@FDA under application 209218 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient CEFTRIAXONE SODIUM Form and strength INJECTABLE;INJECTION - EQ 10GM BASE/VIAL Sponsor QILU ANTIBIOTICS Submission history Latest submission status date: 2022-01-13 00:00:00.
Structured Monograph
Clinical summary
Approval overview CEFTRIAXONE is listed in Drugs@FDA under application 209218 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CEFTRIAXONE SODIUM Form and strength INJECTABLE;INJECTION - EQ 10GM BASE/VIAL Sponsor QILU ANTIBIOTICS Submission history Latest submission status date: 2022-01-13 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.